ArticleFrontiers in pediatrics2026
Clinical and imaging features in the differentiation of pediatric pulmonary tuberculosis and pneumonia.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the clinical and Imaging characteristics between children with pediatric pulmonary tuberculosis (PTB) and children with pneumonia who were initially suspected of PTB, and to explore valuable indicators for differential diagnosis. Methods: This retrospective study enrolled pediatric inpatients initially suspected of PTB at Guangzhou Chest Hospital from March 2020 to May 2021. All participants were divided into the PTB group and the control group. Clinical characteristics, laboratory results, and chest computed tomography (CT) imaging findings were compared between the two groups. On the basis of univariate analysis, variables were further screened via the least absolute shrinkage and selection operator (LASSO) regression with reference to clinical significance. A stable and reliable predictive model was finally established using Firth penalized logistic regression. Results: A total of 63 children were enrolled in this study. Among them, 48 were finally diagnosed with PTB, including 23 cases with etiological confirmation and 25 cases with clinical diagnosis, which constituted the PTB group. The remaining 15 children were diagnosed with pneumonia and assigned to the control group. Compared with the control group, the PTB group had a significantly higher rate of tuberculosis contact history, longer pre-hospital symptom duration, and higher rates of pre-hospital antibiotic and systemic glucocorticoid use. In terms of chest CT manifestations, multiple pulmonary nodules, hilar/mediastinal/axillary lymphadenopathy, calcification, and fine linear or reticular opacities were significantly more common in the PTB group. The final predictive model was constructed based on the two most differentiating imaging features, namely multiple pulmonary nodules and hilar/mediastinal/axillary lymphadenopathy, and presented excellent diagnostic efficacy. The area under the receiver operating characteristic curve was 0.99. The corresponding sensitivity, specificity and overall accuracy were 93.75%, 100% and 95.24%, respectively. Conclusion: This study preliminarily developed an imaging model based on multiple pulmonary nodules and hilar/mediastinal/axillary lymphadenopathy, which may assist in distinguishing pediatric PTB from pneumonia. However, given the single-center, specialized-hospital setting of this study and the exclusion of certain patient subgroups, the generalizability of these findings is limited. Therefore, the conclusions require validation through future multicenter, large-scale prospective studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.